Balter Liquid Alternatives’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,201
Closed -$139K 158
2019
Q1
$139K Buy
+4,201
New +$139K 0.08% 162